A Study Of Healthy Donors For HNA

Overview

About this study

The purpose of this study is to obtain Granulocytes from donors with known HNA phenotype are needed for clinical HNA assay.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Healthy participants; not on medication; are able to commit to a year in the study

Exclusion Criteria:

Diseased patients; those with long-term medication; have chronic conditions; those who are other wise un-healthy.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/5/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Manish Gandhi, M.D.	Open for enrollment	Contact information: Ginno Huarocc 5072849911 huarocc.ginno@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Manish Gandhi, M.D.

Open for enrollment

Contact information:

Ginno Huarocc

5072849911

huarocc.ginno@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials